Sfoglia per AUTORE
CAMPISI G
Collezione AOU Alessandria

  

Items : 15

Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS. in Journal of bone oncology / J Bone Oncol. 2024 Dec 16;50:100656. doi: 10.1016/j.jbo.2024.100656. eCollection 2025 Feb.

2025
AOU Alessandria

Guglielmi G; Romeo U; Bedogni A; Palermo A; Pepe J; Mauceri R; Fusco V; Bertoldo F; Eller-Vainicher C; Campisi G;

Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ). in Oral diseases / Oral Dis. 2024 Sep;30(6):3679-3709. doi: 10.1111/odi.14887. Epub 2024 Feb 5.

2024
AOU Alessandria

Saia G; Panzarella V; Marchetti C; Lo Casto A; Di Fede O; Bettini G; Bertoldo F; Fusco V; Mauceri R; Bedogni A; Vescovi P; Campisi G;

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021). in Oral diseases / Oral Dis. 2024 Oct 6. doi: 10.1111/odi.15145.

2024
AOU Alessandria

Capuano A; Fusco V; Marrazzo E; Geninatti E; Parrinello G; Zinzi A; Morreale I; Bellavia G; Gaio M; Sottosanti L; Oteri G; Potenza S; Colella G; La Mantia G; Panzarella V; Sportiello L; Campisi G;

Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?". in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA / Osteoporos Int. 2024 Nov;35(11):2071-2072. doi: 10.1007/s00198-024-07192-4. Epub 2024 Aug 16.

2024
AOU Alessandria

Bertoldo F; Fusco V; Bedogni A; Coppini M; Mauceri R; Campisi G;

Correction: Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?". in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA / Osteoporos Int. 2024 Nov;35(11):2073. doi: 10.1007/s00198-024-07245-8.

2024
AOU Alessandria

Bertoldo F; Fusco V; Bedogni A; Coppini M; Mauceri R; Campisi G;

MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series. in BMC oral health / BMC Oral Health. 2023 Feb 4;23(1):71. doi: 10.1186/s12903-023-02732-6.

2023
AOU Alessandria

Oteri G; Leonardi RM; Nisi M; Isola G; Marcianò A; Graziani F; Giudice A; Fusco V; Bettini G; Bedogni A; Attanasio M; Coppini M; Mauceri R; Toro C; Campisi G;

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost-benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ). in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2022 Sep;30(9):7047-7051. doi: 10.1007/s00520-022-06982-y. Epub 2022 Mar 21.

2022
AOU Alessandria

Bedogni A; Campisi G; Fusco V;

The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2022 Aug;30(8):6429-6440. doi: 10.1007/s00520-022-06940-8. Epub 2022 Mar 16.

2022
AOU Alessandria

Bertoldo F; Fusco V; Di Fede O; Tomassi D; Panzarella V; Carcieri P; Abbinante A; Coniglio R; Mauceri R; Bedogni A; Campisi G;

A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis. in Head & face medicine / Head Face Med. 2021 Jul 9;17(1):25. doi: 10.1186/s13005-021-00280-4.

2021
AOU Alessandria

Fusco V; Bertoldo F; Mauceri R; Campisi G; Bedogni A;

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Aug 10;18(16):8432. doi: 10.3390/ijerph18168432.

2021
AOU Alessandria

Di Fede O; Canepa F; Panzarella V; Mauceri R; Del Gaizo C; Bedogni A; Fusco V; Tozzo P; Pizzo G; Campisi G; Galvano A;

Adjuvant denosumab in early breast-cancer. in The Lancet. Oncology / Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8.

2020
AOU Alessandria

Fusco V; Campisi G; Bedogni A; Fusco V; Campisi G; Bedogni A;

Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary. in JCO oncology practice / JCO Oncol Pract. 2020 Mar;16(3):142-145. doi: 10.1200/JOP.19.00645. Epub 2020 Jan 24.

2020
AOU Alessandria

Fusco V; Santini D; Campisi G; Bertoldo F; Lanzetta G; Ibrahim T; Bertetto O; Numico G; Addeo A; Berruti A; Bettini G; Saia G; Bedogni A;

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. in International journal of environmental research and public health / Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998.

2020
AOU Alessandria

Campisi G; Mauceri R; Bertoldo F; Bettini G; Biasotto M; Colella G; Consolo U; Di Fede O; Favia G; Fusco V; Gabriele M; Lo Casto A; Lo Muzio L; Marcianò A; Mascitti M; Meleti M; Mignogna MD; Oteri G; Panzarella V; Romeo U; Santarelli A; Vescovi P; Marchetti C; Bedogni A;

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on Lancet Oncology. in Dentistry journal / Dent J (Basel). 2018 Sep 1;6(3):42. doi: 10.3390/dj6030042.

2018
AOU Alessandria

Fusco V; Campisi G; de Boissieu P; Monaco F; Baraldi A; Numico G; Bedogni A;

The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention. in BioMed research international / Biomed Res Int. 2018 Sep 16;2018:2684924. doi: 10.1155/2018/2684924. eCollection 2018.

2018
AOU Alessandria

Di Fede O; Panzarella V; Mauceri R; Fusco V; Bedogni A; Lo Muzio L; Sipmo Onj Board; Campisi G;